Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning Balance, Stockholders' equity (in shares) at Dec. 31, 2022		30,968,000
Beginning Balance, Stockholders' equity at Dec. 31, 2022	$ 138,582	$ 30	$ 271,884	$ (4,662)	$ (128,670)
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (in shares)		134,000
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes	(87)	$ 1	(88)
Stock-based compensation	4,486		4,486
Net loss	(23,817)				(23,817)
Other comprehensive loss	(1,949)			(1,949)
Ending Balance, Stockholders' equity (in shares) at Mar. 31, 2023		31,102,000
Ending Balance, Stockholders' equity at Mar. 31, 2023	$ 117,215	$ 31	276,282	(6,611)	(152,487)
Beginning Balance, Stockholders' equity (in shares) at Dec. 31, 2023	32,122,000	32,122,000
Beginning Balance, Stockholders' equity at Dec. 31, 2023	$ 22,559	$ 31	294,863	(8,447)	(263,888)
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes (in shares)		53,000
Issuance of common stock upon vesting of restricted stock units, exercise of stock options and employee stock plan purchases, net of shares withheld for taxes	(33)		(33)
Issuance of common stock in public offering, net of issuance costs	9,925	$ 5	9,920
Private placement of shares		5,435,000
Stock-based compensation	2,608		2,608
Net loss	(18,706)				(18,706)
Other comprehensive loss	$ (1,358)			(1,358)
Ending Balance, Stockholders' equity (in shares) at Mar. 31, 2024	37,610,000	37,610,000
Ending Balance, Stockholders' equity at Mar. 31, 2024	$ 14,995	$ 36	$ 307,358	$ (9,805)	$ (282,594)